The role of taurine on chemotherapy-induced cardiotoxicity: A systematic review of non-clinical study
| Autor: | Mohammad Abdollahi, Behnaz Bameri, Hamed Haghi-Aminjan, Mastoureh Naddafi, Mohammad Ali Eghbal, Maryam Armandeh, Mohammadreza Sattari, Mahedeh Samadi, Mohammad Reza Hooshangi Shayesteh |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Taurine Cyclophosphamide medicine.medical_treatment Anti-Inflammatory Agents Antineoplastic Agents Apoptosis Pharmacology 030226 pharmacology & pharmacy Antioxidants General Biochemistry Genetics and Molecular Biology 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Neoplasms medicine Animals Humans Doxorubicin General Pharmacology Toxicology and Pharmaceutics Cisplatin Cardiotoxicity Chemotherapy business.industry Cancer General Medicine medicine.disease 030104 developmental biology chemistry Inclusion and exclusion criteria business medicine.drug |
| Zdroj: | Life Sciences. 265:118813 |
| ISSN: | 0024-3205 |
| DOI: | 10.1016/j.lfs.2020.118813 |
| Popis: | Aims Although chemotherapeutic agents have highly beneficial effects against cancer, they disturb the body's normal homeostasis. One of the critical side effects of chemotherapeutic agents is their deleterious effect on the cardiac system, which causes limitations of their clinical usage. Taurine constitutes more than 50% of the amino acids in the heart. The use of taurine might prevent chemotherapy-induced cardiotoxicity. This systematic study aims to evaluate the protective role of taurine against cardiotoxicity induced by chemotherapy. Methods A systematic search was performed in databases up to November 2020, and the review is designed on PRISMA guidelines. The search keywords were selected based on our study target and were searched in the title and abstract. After the consecutive screening, out of a whole of 94 articles, 8 articles were included according to our inclusion and exclusion criteria. Key findings According to the study results, chemotherapy decreases body and heart weight and increases mortality. Also, it induces some biochemical and histological changes compared to the control group. By co-administration of taurine with chemotherapy, alterations returned near to the average level. These protective effects of taurine are mediated through anti-oxidant, anti-inflammatory, and anti-apoptotic properties. Significance Based on evaluated non-clinical studies, taurine ameliorates chemotherapy-induced cardiotoxicity, but its possible interaction with the efficacy of anti-cancer medicines that mostly act through induction of oxidants remains to be elucidated in the future. This needs conducting well-designed studies to assess the effectiveness and safety of this combination simultaneously. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect